HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata

Clinical trial NCT07049328 · RECRUITING

Trial details

NCT number: NCT07049328
Sponsor: HCW Biologics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alopecia Areata(AA)

Start date: 2025-08-16
Primary completion: 2026-07-16
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.